Experts discuss recent data on next generation sequencing and germline testing in patients with advanced and metastatic cancer.
Mark Robson, MD, and a panel of experts discuss key terminology and definitions related to tumor and germline sequencing.
Mark Robson, MD, reviews data from a recent abstract on incidental germline findings detected by tumor-normal matched sequencing and the panelists share which platforms they utilize for tumor profiling.
A panel of experts share their experiences with interpreting information on somatic reports and provide recommendations for verifying results.
Mark Robson, MD; John Henson, MD; Ashley Ross, MD, PhD; and Dana Farengo Clark, MS, LCGC, discuss the evolving role of circulating tumor DNA (ctDNA) in germline testing.
Mark Robson, MD; John Henson, MD; Ashley Ross, MD, PhD; and Dana Farengo Clark, MS, LCGC, discuss operational processes and techniques for counseling patients about germline testing.